Aducanumab: A Deep Dive into BIIB037 and its Impact A compound, initially known as BIIB037, constitutes a complex endeavor to treat emerging Alzheimer's disease. Developed by Biogen, this molecule works by removing https://www.targetmol.com/compound/aducanumab